Nxera Pharma Revenue

Nxera Pharma had revenue of 6.75B JPY in the quarter ending September 30, 2025, a decrease of -27.09%. This brings the company's revenue in the last twelve months to 28.70B, down -1.96% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

Revenue (ttm)

28.70B JPY

Revenue Growth

-1.96%

P/S Ratio

2.57

Revenue / Employee

76.74M JPY

Employees

374

Market Cap

424.62M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%
Dec 31, 2020	8.84B	-884.00M	-9.09%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Mercedes-Benz Group AG	136.97B
Bayerische Motoren Werke Aktiengesellschaft	136.42B
Deutsche Telekom AG	121.02B
Allianz SE	105.02B
Siemens Aktiengesellschaft	78.91B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	62.10B
Siemens Energy AG	39.08B
SAP SE	36.49B

Revenue Rankings